Changed/stopped drugs due to maternal side‐effects · women with mild to moderate hypertension during pregnancy
Any antihypertensive drug showed no clear difference in changed/stopped drugs due to maternal side‐effects compared with no antihypertensive drugs/placebo (low certainty).
1 finding from 1 review
Maternal · women with mild to moderate hypertension during pregnancy
The review found no eligible studies for this question.
2 findings from 1 review
no estimate extracted
Studies not reported
No studies found
no estimate extracted
Studies not reported
No studies found
Severe pre‐eclampsia · women with mild to moderate hypertension during pregnancy
It is very uncertain whether any antihypertensive drug changes severe pre‐eclampsia compared with no antihypertensive drugs/placebo (very low certainty).
1 finding from 1 review
Eclampsia · women with mild to moderate hypertension during pregnancy
It is very uncertain whether any antihypertensive drug changes eclampsia compared with no antihypertensive drugs/placebo (very low certainty).
1 finding from 1 review
Elective delivery (induction of labour + elective caesarean section) · women with mild to moderate hypertension during pregnancy
Any antihypertensive drug showed no clear difference in elective delivery (induction of labour + elective caesarean section) compared with no antihypertensive drugs/placebo (moderate certainty).
1 finding from 1 review
Fetal/neonatal/infant · women with mild to moderate hypertension during pregnancy
The review found no eligible studies for this question.
2 findings from 1 review
no estimate extracted
Studies not reported
No studies found
no estimate extracted
Studies not reported
No studies found
Admission to neonatal or intensive care nursery · women with mild to moderate hypertension during pregnancy
Any antihypertensive drug showed no clear difference in admission to neonatal or intensive care nursery compared with no antihypertensive drugs/placebo (low certainty).
1 finding from 1 review
Severe hypertension · women with mild to moderate hypertension during pregnancy
Any antihypertensive drug probably leads to lower severe hypertension compared with no antihypertensive drugs/placebo (moderate certainty).
1 finding from 1 review
Proteinuria/pre‐eclampsia · women with mild to moderate hypertension during pregnancy
Any antihypertensive drug showed no clear difference in proteinuria/pre‐eclampsia compared with no antihypertensive drugs/placebo (low certainty).
1 finding from 1 review
Total reported fetal or neonatal deaths (including miscarriage) · women with mild to moderate hypertension during pregnancy
Any antihypertensive drug showed no clear difference in total reported fetal or neonatal deaths (including miscarriage) compared with no antihypertensive drugs/placebo (moderate certainty).
1 finding from 1 review
Small‐for‐gestational age · women with mild to moderate hypertension during pregnancy
Any antihypertensive drug showed no clear difference in small‐for‐gestational age compared with no antihypertensive drugs/placebo (moderate certainty).
1 finding from 1 review
Preterm birth · women with mild to moderate hypertension during pregnancy
Any antihypertensive drug showed no clear difference in preterm birth (< 37 weeks) compared with no antihypertensive drugs/placebo (moderate certainty).
1 finding from 1 review
Maternal death · women with mild to moderate hypertension during pregnancy
It is very uncertain whether any antihypertensive drug changes maternal death compared with no antihypertensive drugs/placebo (very low certainty).
1 finding from 1 review
Angiotensin receptor blocker (any dose) Mean duration of 4 weeks · children (from 1 to 18 years of age) with hypertension from primary or secondary causes
2 findings from 1 review
Beta‐blocker (any dose) Mean duration of 4 weeks · children (from 1 to 18 years of age) with hypertension from primary or secondary causes
2 findings from 1 review
Calcium channel blocker (any dose) Mean duration of 3 weeks · children (from 1 to 18 years of age) with hypertension from primary or secondary causes
2 findings from 1 review
Beta‐blocker/thiazide combination (any dose) Mean duration of 10 weeks · children (from 1 to 18 years of age) with hypertension from primary or secondary causes
2 findings from 1 review